{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:08:53Z","timestamp":1789729733323,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Education Commission scientific research project","award":["2024KJ243"],"award-info":[{"award-number":["2024KJ243"]}]},{"name":"Tianjin Education Commission scientific research project","award":["2024KJ243"],"award-info":[{"award-number":["2024KJ243"]}]},{"name":"Tianjin Education Commission scientific research project","award":["2024KJ243"],"award-info":[{"award-number":["2024KJ243"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-025-01691-6","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T17:35:39Z","timestamp":1752773739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of \u03b1-SMA\/FAP-positive cancer-associated fibroblasts with clinicopathological features and prognosis in extrahepatic cholangiocarcinoma"],"prefix":"10.1186","volume":"20","author":[{"given":"Xiaojun","family":"Sui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangqiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"issue":"2","key":"1691_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/hep.32624","volume":"77","author":"M Deng","year":"2023","unstructured":"Deng M, Ran P, Chen L, et al. Proteogenomic characterization of cholangiocarcinoma. Hepatology. 2023;77(2):411\u201329.","journal-title":"Hepatology"},{"issue":"9","key":"1691_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"1691_CR3","first-page":"957","volume":"21","author":"C Chuaysri","year":"2009","unstructured":"Chuaysri C, Thuwajit P, Paupairoj A, et al. Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma. Oncol Rep. 2009;21(4):957\u201369.","journal-title":"Oncol Rep"},{"key":"1691_CR4","doi-asserted-by":"crossref","unstructured":"Cantallops Vil\u00e0 P, Ravichandra A, Agirre Lizaso A et al. Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma. Hepatology. 2023 Jan 3.","DOI":"10.1097\/HEP.0000000000000206"},{"issue":"11","key":"1691_CR5","doi-asserted-by":"publisher","first-page":"e146987","DOI":"10.1172\/JCI146987","volume":"131","author":"S Bhattacharjee","year":"2021","unstructured":"Bhattacharjee S, Hamberger F, Ravichandra A, et al. Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. J Clin Invest. 2021;131(11):e146987.","journal-title":"J Clin Invest"},{"issue":"6","key":"1691_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.ccell.2021.05.010","volume":"39","author":"S Affo","year":"2021","unstructured":"Affo S, Nair A, Brundu F, et al. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell. 2021;39(6):883.","journal-title":"Cancer Cell"},{"key":"1691_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","volume":"12","author":"S Affo","year":"2017","unstructured":"Affo S, Yu LX, Schwabe RF. The role of Cancer-Associated fibroblasts and fibrosis in liver Cancer. Annu Rev Pathol. 2017;12:153\u201386.","journal-title":"Annu Rev Pathol"},{"issue":"9","key":"1691_CR8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582\u201398.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1691_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4161\/cbt.13.3.18696","volume":"13","author":"R Liu","year":"2012","unstructured":"Liu R, Li H, Liu L, et al. Fibroblast activation protein: A potential therapeutic target in cancer. Cancer Biol Ther. 2012;13(3):123\u20139.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"1691_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yue X, Chen Z, et al. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol Cancer. 2023;22(1):159.","journal-title":"Mol Cancer"},{"key":"1691_CR11","volume-title":"AJCC Cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge S, Greene F, et al. AJCC Cancer staging manual. 8th ed. New York, NY: Springer; 2017.","edition":"8"},{"issue":"2","key":"1691_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3892\/or.2020.7890","volume":"45","author":"Z Guo","year":"2021","unstructured":"Guo Z, Zhang X, Zhu H, et al. TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2. Oncol Rep. 2021;45(2):523\u201334.","journal-title":"Oncol Rep"},{"key":"1691_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.canlet.2018.05.031","volume":"430","author":"S Thongchot","year":"2018","unstructured":"Thongchot S, Ferraresi A, Vidoni C, et al. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells. Cancer Lett. 2018;430:160\u201371.","journal-title":"Cancer Lett"},{"issue":"9","key":"1691_CR14","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1002\/cam4.1704","volume":"7","author":"M Sha","year":"2018","unstructured":"Sha M, Jeong S, Qiu BJ, et al. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma. Cancer Med. 2018;7(9):4665\u201377.","journal-title":"Cancer Med"},{"issue":"14","key":"1691_CR15","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","volume":"76","author":"X Yang","year":"2016","unstructured":"Yang X, Lin Y, Shi Y, et al. FAP promotes immunosuppression by Cancer-Associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res. 2016;76(14):4124\u201335.","journal-title":"Cancer Res"},{"issue":"6","key":"1691_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","volume":"20","author":"TF Greten","year":"2023","unstructured":"Greten TF, Schwabe R, Bardeesy N, et al. Immunology and immunotherapy of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2023;20(6):349\u201365.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"1691_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund D, Handly-Santana A, Biffi G, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214(3):579\u201396.","journal-title":"J Exp Med"},{"issue":"9","key":"1691_CR18","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ccell.2024.08.011","volume":"42","author":"L Cords","year":"2024","unstructured":"Cords L, de Souza N, Bodenmiller B. Classifying cancer-associated fibroblasts-The good, the bad, and the target. Cancer Cell. 2024;42(9):1480\u20135.","journal-title":"Cancer Cell"},{"key":"1691_CR19","doi-asserted-by":"crossref","unstructured":"Sheng N, Shindo K, Ohuchida K et al. TAK1 promotes an immunosuppressive tumor microenvironment through Cancer-Associated fibroblast phenotypic conversion in pancreatic ductal adenocarcinoma. Clin Cancer Res. 2024 Sep 12.","DOI":"10.1158\/1078-0432.c.7541176"},{"issue":"1","key":"1691_CR20","first-page":"133","volume":"16","author":"D Waseem","year":"2017","unstructured":"Waseem D, Tushar P. Intrahepatic, Perihilar and distal cholangiocarcinoma: management and outcomes. Ann Hepatol 2017 Jan-Feb. 2017;16(1):133\u20139.","journal-title":"Ann Hepatol 2017 Jan-Feb"},{"issue":"4","key":"1691_CR21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/00031348211034751","volume":"89","author":"A Istanbouli","year":"2023","unstructured":"Istanbouli A, Patel S, Almerey T, et al. Surgical treatment for intrahepatic, Peri-Hilar, and distal cholangiocarcinoma: 20-Single institutional year experience. Am Surg. 2023;89(4):621\u201331.","journal-title":"Am Surg"},{"issue":"4","key":"1691_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.14701\/ahbps.2019.23.4.319","volume":"23","author":"P Jung","year":"2019","unstructured":"Jung P, Cho EH, Kim SB, et al. Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg. 2019;23(4):319\u201326.","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"issue":"2","key":"1691_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4174\/astr.2022.102.2.100","volume":"102","author":"JM Lee","year":"2022","unstructured":"Lee JM, Kim H, Sohn HJ, et al. Comparison of oncologic outcomes of extrahepatic cholangiocarcinoma according to tumor location: Perihilar cholangiocarcinoma versusdistal bile duct cancer. Ann Surg Treat Res. 2022;102(2):100\u20139.","journal-title":"Ann Surg Treat Res"},{"issue":"19","key":"1691_CR24","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.3390\/cancers15194691","volume":"15","author":"D Moris","year":"2023","unstructured":"Moris D. Surgical management of intrahepatic cholangiocarcinoma: quo vadis. Cancers (Basel). 2023;15(19):4691.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1691_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.soc.2013.10.005","volume":"23","author":"VM Zaydfudim","year":"2014","unstructured":"Zaydfudim VM, Rosen CB, Nagorney DM. Hilar cholangiocarcinoma. Surg Oncol Clin N Am. 2014;23(2):247\u201363.","journal-title":"Surg Oncol Clin N Am"},{"issue":"7","key":"1691_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","volume":"3","author":"D Lavie","year":"2022","unstructured":"Lavie D, Ben-Shmuel A, Erez N, et al. Cancer-associated fibroblasts in the single-cell era. Nat Cancer. 2022;3(7):793\u2013807.","journal-title":"Nat Cancer"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01691-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01691-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01691-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:09:54Z","timestamp":1757250594000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01691-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1691"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01691-6","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Usage of archived tissues has been approved by the Ethics Committee of Nankai Hospital, Tianjin, China (approval number: NKYY_YXKT_IRB_2023_098_01). All work was performed in compliance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"85"}}